Cargando…
12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT
BACKGROUND: Metastasis of melanoma to the brain is associated with poor outcomes. Recent trials demonstrate improved survival after treatment with immune checkpoint inhibitors. OBJECTIVE: To examine the impact that checkpoint inhibitor treatment has on overall survival (OS) and central nervous syste...
Autores principales: | Morshed, Ramin, Chung, Jason, Sudhakar, Vivek, Cummins, Daniel, Young, Jacob, Daras, Mariza, Aghi, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401329/ http://dx.doi.org/10.1093/noajnl/vdaa073.004 |
Ejemplares similares
-
SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series
por: Morshed, Ramin, et al.
Publicado: (2021) -
LOCL-06 SUPERVISED MACHINE LEARNING IDENTIFIES RISK FACTORS ASSOCIATED WITH LEPTOMENINGEAL DISEASE AFTER SURGICAL RESECTION OF BRAIN METASTASES
por: Morshed, Ramin, et al.
Publicado: (2022) -
CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases
por: Morshed, Ramin A, et al.
Publicado: (2023) -
Surgical advances in the management of brain metastases
por: Ng, Patrick R, et al.
Publicado: (2021) -
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2023)